GAS6 in systemic inflammatory diseases: with and without infection

Crit Care. 2010;14(5):1003. doi: 10.1186/cc9263. Epub 2010 Oct 21.

Abstract

Vitamin K-dependent proteins are not only essential regulators of blood coagulation. A recent paper in Critical Care describes the levels of the vitamin K-dependent GAS6 and the soluble form of its receptor Axl in plasma from patients with sepsis of systemic inflammation. The results confirm that GAS6 is elevated during septicemia, but the fact that inflammatory conditions without infection produce a similar effect suggests it is inflammation that induces the synthesis of GAS6, rather than the interactions with bacteria or other infectious agents. The soluble form of the GAS6 receptor Axl was induced less compared with the effect observed in GAS6. This is important as the two proteins form an inactive complex in plasma, suggesting that a functional GAS6 form could be synthesized under these conditions. GAS6 has been proposed as a broad regulator of the innate immune response. GAS6 synthesis is therefore likely to be a regulatory mechanism during systemic inflammation. Recent advances provide the necessary tools for further research, including genetic screenings of the components of this system.

Publication types

  • Comment

MeSH terms

  • Biomarkers / blood
  • Humans
  • Intercellular Signaling Peptides and Proteins / blood*
  • Systemic Inflammatory Response Syndrome / blood*
  • Systemic Inflammatory Response Syndrome / microbiology*
  • Systemic Inflammatory Response Syndrome / pathology
  • Vitamin K / blood

Substances

  • Biomarkers
  • Intercellular Signaling Peptides and Proteins
  • growth arrest-specific protein 6
  • Vitamin K